Clinical Trials List
2017-03-15 - 2024-12-31
Phase III
Terminated6
ICD-10D59.5
Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]
ICD-10D59
Acquired hemolytic anemia
ICD-9283.2
Hemoglobinuria due to hemolysis from external causes
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- HSIN-AN HOU Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- 郭景元 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Ya-Ping Chen Division of Hematology & Oncology
- Ya-Ting Hsu Division of Hematology & Oncology
- Sin-Syue Li Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 王佐輔 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
214 participants
